By Memorial Sloan-Kettering | Monday, February 20, 2012
When five-year-old CJ Postighone was diagnosed with a rare pediatric cancer called rhabdomyosarcoma, he came to Memorial Sloan-Kettering to receive a combination of surgery, chemotherapy, and radiation therapy.
By Memorial Sloan-Kettering | Wednesday, February 15, 2012
The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan-Kettering.
By Memorial Sloan-Kettering | Monday, February 13, 2012
Soon after Halina Frydman’s husband noticed changes in his wife's personality, Halina was diagnosed with primary central nervous system lymphoma. She came to Memorial Sloan-Kettering to receive treatment through a clinical trial.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Tuesday, February 7, 2012
The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.
In the News
By Julie Grisham, MS, Science Writer/Editor | Monday, February 6, 2012
Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.
In the News
By Media Staff | Friday, February 3, 2012
The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.
In the Lab
By Jim Stallard, MA, Writer/Editor | Wednesday, February 1, 2012
Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, January 31, 2012
Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.
By Memorial Sloan-Kettering | Monday, January 30, 2012
While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.
By Memorial Sloan-Kettering | Wednesday, January 25, 2012
Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.
By Esther Napolitano, BS, Science Writer/Editor | Monday, January 23, 2012
Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan-Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, January 20, 2012
Infections are a common cause of complications in cancer patients. Now a Memorial Sloan-Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.
By Memorial Sloan-Kettering | Thursday, January 19, 2012
When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan-Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.
By Memorial Sloan-Kettering | Tuesday, January 17, 2012
The Spine Tumor Center at Memorial Sloan-Kettering provides state-of-the-art diagnostic and treatment services for more than 1,500 people with primary or metastatic spine tumors each year.
In the Clinic
By Media Staff | Friday, January 13, 2012
Researchers at Memorial Sloan-Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.